High expression of CCR5 in melanoma enhances epithelial ‐to‐mesenchymal transition and metastasis via TGFβ1

AbstractChemokine receptors are highly expressed in various cancers and play crucial roles in tumor progression. However, their expression patterns and functions in melanoma are unclear. The present study aimed to identify the chemokine receptors that play critical roles in melanoma progression and unravel the underlying molecular mechanisms. We found that the C ‐C chemokine receptor 5 (CCR5) was more abundant in melanoma cells than normal cells and was positively associated with tumor malignancy in clinical patients. Animal experiments suggested that CCR5 deficiency in B16/F10 or A375 cells suppressed primary tumor growth and lung metastasis, while CCR5o verexpression in B16/F0 cells enhanced primary tumor growth and lung metastasis. CCR5 played a critical role in proliferation and migration of melanoma cellsin vitro. Importantly, CCR5 was required for maintenance of the mesenchymal phenotype of metastatic melanoma cells. Mechanistically, CCR5 positively regulated expression of Transforming Growth Factor β1 (TGFβ1), which in turn induced epithelial‐mesenchymal transition (EMT) and migrationvia PI3K/AKT/GSK3 β signaling. Collectively, our results establish a critical role of CCR5 expressed by melanoma cells in cancer progression and reveal the novel mechanisms controlling this process, which suggests the prognostic value of CCR5 in melanoma patients and provides novel insights into CCR5‐targeted stra tegies for melanoma treatment.
Source: The Journal of Pathology - Category: Pathology Authors: Tags: Original Paper Source Type: research